pharma · Dengue Fever · Chronic Babesiosis · SXTP
60 DEGREES PHARMACEUTICALS
60 DEGREES PHARMACEUTICALS, INC.
60 Degrees Pharmaceuticals is a pharma organization headquartered in Washington, USA. It trades on NYSE under ticker SXTP. Primary therapeutic focus areas include Dengue Fever, Chronic Babesiosis, Babesiosis, COVID 19 Di
Washington, USA HQ
2010 Founded
6 Employees
Public company Type
SXTP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Washington, USA
- Founded
- 2010
- Employees
- 6
- Programs
- 5
- Drugs
- 2
- Patents
- 0
Celgosivir
Phase 2 · small molecule · Dengue Fever
Celgosivir for Dengue Fever is a Phase 2 program (small_molecule) at 60 DEGREES PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Internal code Cel01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- 60 DEGREES PHARMACEUTICALS, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Dengue Fever
- Status
- terminated
- Trials
- 1